Abstract VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) is a newly
characterized syndrome with underlying somatic UBA1 mutations in myeloid cells linking …

In 2020, Beck et al 1 described a novel adult autoinflammatory syndrome entitled VEXAS
(Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic), a newly-discovered disorder …

The objective of this study is to describe the clinical features and outcomes of patients with
the newly defined vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) …

Abstract VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a
newly-described adult-onset inflammatory syndrome characterized by vacuoles in myeloid …

Abstract VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a
recently described autoinflammatory syndrome characterized by diffuse inflammatory …

VEXAS syndrome, an autoinflammatory syndrome due to a Ubiquitin Like Modifier Activating
Enzyme 1 (UBA1) somatic mutation, has a high thrombotic burden. We report a case of a 69 …

Background VEXAS (vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic) syndrome
is an autoinflammatory disease with frequent cutaneous manifestations. Methods We …

Vacuoles, E1 enzyme, X linked, autoinflammatory, somatic (VEXAS) syndrome is a recently
described X-linked autoinflammatory condition associated with somatic mutation of the …

Future studies and experiences are needed in order to determine the best strategy for allo-
HSCT in patients with the VEXAS syndrome. Recently, a cohort of six patients who were …

DEAR EDITOR, VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic)
syndrome is an acquired multisystemic auto-inflammatory condition due to somatic …